(MedPage Today) — Treating psoriatic arthritis (PsA) patients with more than one targeted therapy appears to be just fine, with no increased risk of serious infections, insurance claims data indicate.
Among some 53,000 patients taking targeted…
Source link : https://www.medpagetoday.com/rheumatology/arthritis/117081
Author :
Publish date : 2025-08-20 15:00:00
Copyright for syndicated content belongs to the linked Source.
